Skip to content
Screener

Gilead Sciences GILD Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.34B-12.2%
Incyte logo
IncyteINCY
$124.52M-30.8%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$472K+27.6%
Precigen logo
PrecigenPGEN
$106K
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$18.88M+44.8%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$10.92M+20.6%

Other financials

Income statement

See full
Revenue$7.8B+10.2%
Gross profit$6.2B+11.5%
Operating income-$10.4B-520%
Net income-$10.5B-636%
EPS (diluted)-$8.45-642%

Balance sheet

See full
Cash & equivalents$3.2B-38.2%
Total debt$26.2B+5.2%
Total equity$11.8B-39.9%
Total assets$49.4B-11.4%

Cash flow

See full
Operating cash flow$3.6B+332%
CapEx$140.0M+30.8%
Free cash flow$3.4B+377%

Valuation

See full
Market cap$162.47B+18.4%
Enterprise value$185.54B+18.2%
P/S5.3×+0.6×

Profitability

See full
Gross margin79.6%+1.1pp
Operating margin-8.2%-36.1pp
Net margin-10.6%-32.5pp
FCF margin42.5%+10.0pp

Returns & leverage

See full
Return on equity-20.6%-53.8pp
Debt / equity2.2×+1.0×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The source filing: Gilead Sciences’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000882095-26-000031

FAQ

What is Gilead Sciences's other non-current liabilities?
Gilead Sciences (GILD) reported other non-current liabilities of $1.49B in Q2 2026.
How has Gilead Sciences's other non-current liabilities changed year-over-year?
Gilead Sciences's other non-current liabilities increased by 15.5% year-over-year, from $1.29B to $1.49B.
What is the long-term trend for Gilead Sciences's other non-current liabilities?
Over 5 years (2020 to 2025), Gilead Sciences's other non-current liabilities has grown at a -0.8% compound annual growth rate (CAGR), from $1.21B to $1.17B.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Ask your AI about Gilead Sciences's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude